Cramer’s lightning round: Vir and GlaxoSmithKline ‘may have something’ that could fight omicron

Business

Loading chart…

Vir Biotechnology (VIR): “[George Scangos] runs that company. And I have to tell you he’s part of a GlaxoSmithKline [alliance]. And I spend a lot of time talking to GlaxoSmithKline. They may have something that could be very, very good against omicron. It’s very early, very early. But I like it. I think you should own the stock.”

Loading chart…

Enbridge (ENB): “That stock has just been in a house of pain. However, it does yield 7%. That’s [CEO] Al Monaco. They’ve got a great long term business. I don’t understand why it’s going down, other than being brought down by the fact that oil suddenly went from $80 to $70 to $64. Buy Enbridge.”

Loading chart…

On Semiconductor (ON): “We’ve had [CEO] Hassane El-Khoury on multiple times. I think he’s a genius. He put together Cypress with this. He’s got the best automobile chips. He’s got internet of things. That stock is a buy to me.”

Loading chart…

Robinhood (HOOD): “Here’s the problem with Robinhood: They’ve got the wrong customer base. They have a great app. But remember when I had that young person come on and say, ‘Why am I using Robinhood, because I’m tired of Candy Crush.’ There’s got to be more to it than that.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Products You May Like

Articles You May Like

200 Episodes: Tax Notes Talk’s Defining Interviews
Ask Larry: Will Working Part Time Before Filing Reduce My Social Security Benefit Rate?
Just 22% of people give themselves high scores when it comes to financial wellness
How those child tax credit checks may affect your tax refund this year
Mark Cuban says this is ‘the least important part of crypto’ for investors to focus on